Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 700 participants.

Also called NCT07687485

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 700 participants (planned count) (from the registry)
Sponsor
Laplace Interventional, Inc (from the registry)
Registry
  • NCT NCT07687485
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07687485. Randomized; single masking; primary purpose treatment. Start 2026-09-04 (actual); primary completion 2029-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System
Acronym
TRIUMPH
Condition
Severe Tricuspid Valve Regurgitation
Condition
Tricuspid Valve Regurgitation
Condition
Tricuspid Valve Disease
Condition
Cardiovascular Diseases (CVD)
Condition
Heart Valve Diseases
Condition
Tricuspid Valve Insufficiency
Condition
Severe Heart Valve Disease
Condition
Symptomatic Tricuspid Regurgitation
Intervention (Device)
Transcatheter Tricuspid Valve Replacement (TTVR) with Laplace TTVR System
Intervention (Device)
Transcatheter Tricuspid Valve Replacement (TTVR) with Edwards EVOQUE TTVR System
Lead sponsor
Laplace Interventional, Inc (class: industry)

Record details

Record id
cardio:ct-nct07687485
Content hash
8a6dc64b702928805906245433e15c155997c92a7971160b30785fb8ed65ab38